S-1 Impact 6/10 Ipo

$VRHID · Veri MedTech Holdings, Inc.

September 14, 2026 · AI-analyzed SEC filing

Veri Medtech Holdings filed Amendment No. 6 to its S-1 for a firm commitment IPO of 3,750,000 shares at an assumed $4.00 per share, targeting approximately $15 million in gross proceeds. The company operates a medical marijuana card concierge platform through its Veriheal subsidiary and is seeking to uplist from OTC (VRHI) to the Nasdaq Capital Market. Revenue has declined from approximately $17 million in FY2024 to $11 million in FY2025, with H1 2026 revenue of $4.48 million versus $6.12 million in H1 2025.

Price data unavailable.

A declining-revenue cannabis-tech company with a dual-class control structure is attempting a Nasdaq IPO — a rare combination that tests investor appetite for both the sector and the story.

This is a cannabis-tech services IPO attempting a Nasdaq uplisting from OTC, joining a small cohort of cannabis-adjacent companies that have accessed public markets. The declining revenue trajectory contrasts with the growth narrative typically expected in IPO filings.

Revenue is declining sharply — FY2025 fell ~35% YoY to ~$11M and H1 2026 is down ~27% vs. H1 2025. The company operates in the federally illegal cannabis-adjacent space, creating banking, regulatory, and enforcement risk. Dual-class voting structure (Series A Preferred at 80% voting power) entrenche

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →